Scleroderma-like disorders

Autoimmunity Reviews

Volumn 7, Issue 4, 2008, Pages 331-339

  Foti, R ^a   Leonardi, R ^a   Rondinone, R ^b   Di Gangi, M ^a   Leonetti, C ^a   Canova, M ^b   Doria, A ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Scleroderma like; Skin thickening; Systemic sclerosis

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; BETA1A INTERFERON; BLEOMYCIN; COCAINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GEMCITABINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; MELPHALAN; METHOTREXATE; METHYSERGIDE; OCTREOTIDE; PACLITAXEL; PENICILLAMINE; PENTAZOCINE; PEPLEOMYCIN; PREDNISONE; PSORALEN; RITUXIMAB; STEROID; TEGAFUR; THALIDOMIDE; UNINDEXED DRUG; VITAMIN K GROUP;

AUTOIMMUNITY; BLEPHAROCHALASIS; CARCINOID SYNDROME; DIABETES MELLITUS; DISEASE COURSE; EOSINOPHILIA MYALGIA SYNDROME; FASCIITIS; GRAFT VERSUS HOST REACTION; HUMAN; MYELOMA; NEPHROGENIC FIBROSING DERMOPATHY; OSTEOSCLEROSIS; PHENYLKETONURIA; POEMS SYNDROME; PUVA; REVIEW; SCLEREDEMA; SCLERODERMA; SCLEROMYXEDEMA; SKIN DISEASE; SKINFOLD; SOFT TISSUE; TOXIC OIL SYNDROME; WERNER SYNDROME;

DIABETES MELLITUS; EOSINOPHILIA-MYALGIA SYNDROME; FIBROSIS; GRAFT VS HOST DISEASE; HUMANS; MALIGNANT CARCINOID SYNDROME; MELORHEOSTOSIS; PHENYLKETONURIAS; POEMS SYNDROME; PORPHYRIA CUTANEA TARDA; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SCLEROMYXEDEMA; SKIN DISEASES; WERNER SYNDROME;

EID: 39549084098     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.12.004     Document Type: Review

References (40)

1. Chung L., Lin J., Furst D.E., and Fiorentino D. Systemic and localized scleroderma. Clin Dermatol 24 (2006) 374-392
2. Czirják L., and Varjú C. Clinical features of scleroderma-like disorders: a challenge for the rheumatologist. Curr Rheumatol Rev 2 (2006) 369-379
3. Mori Y., Kahari V.M., and Varga J. Scleroderma-like cutaneous syndromes. Curr Rheumatol rep 4 (2002) 113-122
4. Cokonis Georgakis C.D., Falasca G., Georgakis A., and Heymann W.R. Scleromyxedema. Clin Dermatol 24 (2006) 493-497
5. Dinneen A.M., and Dicken C. Scleromyxedema. J Am Acad Dermatol 33 (1995) 37-43
6. Rongioletti F. Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg 25 2 (2006) 100
7. Righi A., Schiavon F., Jablonska S., Doria A., Blasczyk M., Rondinone R., et al. Intravenous immunoglobulins control scleromyxoedema. Ann Rheum Dis 61 (2002) 59-61
8. Graff R. Discussion of scleredema adultorum. Arch Dermatol 98 (1968) 319-320
9. Jablonska S., and Blaszczyk M. Scleroderma-like disorders. Semin Cutan Med Surg 17 (1998) 65-76
10. Beers W.H., Ince A., and Moore T.L. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 35 (2006) 355-359
11. Foti R., Leonardi R., Fichera G., Di Gangi M., Leonetti C., et al. Buschke Scleredema, case report. Reumatismo 58 (2006) 310-313
12. Grobner T., and Prischl F.C. Gadolinium and nephrogenic systemic fibrosis. Kidney intern 72 (2007) 260-264
13. Jimenez S.A., Artlett C.M., Sandorfi N., Derk C., Latinis K., Sawaya, et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Arthritis Rheum 50 (2004) 2660-2666
14. Mendoza F.A., Artlett C.M., Sandorfi N., Latinis K., Piera Velazquez S., and Jimenez S.A. Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35 (2006) 238-249
15. Toussaint P., Sibaud V., Labbe L., and Geniaux M. Poems syndrome revealed by scleroderma-like skin thickening. Ann de Dermatol Venereol 127 (2000) 73-76
16. Dispenzieri A., Kyle R.A., Lacy M.Q., Rajkumar S.V., Therneau T.M., Larson D.R., et al. POEMS syndrome: definitions and long-term outcome. Blood 101 (2003) 2496-2506
17. Dispenzieri A. POEMS Syndrome. Hematology Am Soc Hematol Educ Program (2005) 360-367
18. Paredes-Suarez C., Fernandez-Redondo V., Blanco M.V., Sanchez-Aguilar D., and Toribio J. Multiple myeloma with scleroderma-like changes. JEADV 19 (2005) 500-502
19. Baumann F., Brühlmann P., Andreisek G., Michel B.A., Marincek B., and Weishaupt D. MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR 184 (2005) 169-174
20. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112-113 (2000) 421-432
21. Cepeda E.J., and Reveille J.D. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance. Curr Opin Rheumatol 16 (2004) 723-732
22. Haustein U.F. Scleroderma-like lesions in insulin-dependent diabetes mellitus. JEADV 13 (1999) 50-53
23. Salasche S.J., and Lebwohl M.G. Medical pearl: scleroderma-like skin changes in patients with diabetes mellitus. J Am Acad Dermatol 48 (2003) 109-111
24. Bell H.K., Poston G.J., Vora J., and Wilson N.J.E. Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol 152 (2005) 71-75
25. Rich W. Porphyria cutanea tarda. Postgrad Med 105 (1999) 208-215
26. Al-Mayouf S.M., and Al-Owain M.A. Progressive sclerodermatous skin changes in a child with phenylketonuria. Pediatr Dermatol 23 (2006) 136-138
27. Schaffer J.V., McNiff J.M., Seropian S., Cooper D.L., and Bolognia J. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol 53 (2005) 591-601
28. Ratanatharathorn V., Ayash L., Lazarus H.M., Fu J., and Uberti J.P. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 28 (2001) 121-129
29. Milford Ward A., Udnoon S., Watkins J., Walker A.E., and Darke C.S. Immunological mechanisms in the pathogenesis of vinyl chloride disease. BMJ 1 (1976) 936-938
30. Ho J., Rothchild Y.H., and Sengelmann R. Vitamin B12-associated localized scleroderma and its treatment. Dermatol Surg 30 (2004) 1252-1255
31. Ihn H. A case of peplomycin-induced scleroderma. Br J Dermatol 150 (2004) 1212-1234
32. Ozden M.G., Erel A., erdem O., and Oztast M.O. Dermal fibrosis and cutaneous necrosis after recombinant interferon-β1a injection in a multiple sclerosis patient. JEADV 19 (2005) 112-113
33. Kono T., Ishii M., Negoro N., and Taniguchi S. Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent. J Am Acad Dermatol 42 (2000) 519-520
34. Kupfer I., Balguerie X., Courville P., Chinet P., and Joly P. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 48 (2003) 279-281
35. Girard C. Methysergide-induced scleroderma-like changes of the legs. Br J Dermatol 153 (2005) 224-225
36. Bessis D., Guillot B., Legouffe E., and Guilhou J.J. Gemcitabine-associated scleroderma-like changes of the lower extremities. J Am Acad Dermatol 51 (2004) S74-S76
37. Shivanand G., and Srivastava D.N. Melorheostosis with scleroderma. J Clin Im 28 (2004) 214-215
38. Geng S., Lei X., Toyohara J.P., Zhan P., Wang J., and Tan S. Stiff skin syndrome. JEADV 20 (2006) 729
39. Nijsten T.E., De Moor A., Colpaert C.G., Robert K., Mahieu L.M., and Lambert J. Restrictive dermopathy: a case report and a critical review of all hypotheses of its origin. Pediatric Dermatol 19 (2002) 67-72
40. Hamm H., Traupe H., Brocker E.B., Schubert H., and Kolde G. The scleroatrophic syndrome of Huriez: a cancer-prone genodermatosis. Br J Dermatol 134 (1996) 512-518